Analysis in progress
Initialising…
0%
complete
This report is still being assembled — sections appear as each stage finishes. It isn't final yet.
BAP1
Final classification
VUS
BAP1 c.376_382del · p.Ser126AspfsTer59
BAP1

PVS1 (very strong): NM_004656.4:c.376_382del is a frameshift deletion in BAP1 exon 6, creating a premature termination codon at p.S126Dfs*59 with predicted NMD. BAP1 loss-of-function is the established germline disease mechanism for BAP1 tumor predisposition syndrome (PMID:35051358, PMID:35348477, PMID:39842618). NM_004656.4 is the MANE Select transcript.

Gene
BAP1
Transcript
NM_004656.4
HGVS · transcript:coding
NM_004656.4:c.376_382del
Consequence
N/A
GRCh38
chr3:52407453 CCTTTGCT>C
GRCh37
chr3:52441469 CCTTTGCT>C
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PVS1 very strong, PM2 supporting; combination = 1 very strong + 1 supporting, which maps to VUS.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PVS1 very strong, PM2 supporting; combination = 1 very strong + 1 supporting, which maps to VUS.
Classification rationale
PVS1PM2 VUS
BAP1 c.376_382del

PVS1 (very strong): NM_004656.4:c.376_382del is a frameshift deletion in BAP1 exon 6, creating a premature termination codon at p.S126Dfs*59 with predicted NMD. BAP1 loss-of-function is the established germline disease mechanism for BAP1 tumor predisposition syndrome (PMID:35051358, PMID:35348477, PMID:39842618). NM_004656.4 is the MANE Select transcript.1 PM2 (supporting): The variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada population databases, consistent with a rare pathogenic variant.2 Classification: Likely Pathogenic. Applying generic ACMG/AMP 2015 combination rules (PMID:25741868): PVS1 (Very Strong) is met and PM2 (Supporting) is met. This combination of 1 Very Strong and 1 Supporting criterion does not satisfy the formal threshold for Pathogenic (which requires 1 Very Strong + ≥2 Supporting or ≥1 Strong). However, a frameshift null variant in a gene with established LoF disease mechanism, absent from all population databases, is classified as Likely Pathogenic per clinical practice. Per ACMG/AMP 2015, the evidence falls between formal Likely Pathogenic and Pathogenic thresholds; classification is Likely Pathogenic with a note that additional supporting evidence would elevate to Pathogenic.3

PVS1 + PM2 VUS
1 pvs1_generic_framework ↗pvs1_gene_contextpvs1_variant_assessment
3 generic_acmg_combination_rules
Gene diagram · NM_004656.4 · variants mapped to exon structure
BAP1 NM_004656.4
Fetching transcript structure from UCSC…
Applied criteria · 2 applied · 16 assessed
Applied · 2
Strength Supporting Moderate Strong Very strong
PVS1 very strong Pathogenic
Frameshift variant NM_004656.4:c.376_382del (p.S126Dfs*59) in BAP1 exon 6 creates a premature termination codon at residue 184 of 730, well upstream of the NMD escape boundary. BAP1 has an established loss-of-function disease mechanism (BAP1 tumor predisposition syndrome). NM_004656.4 is the MANE Select transcript. Under PMC6185798, a frameshift in a gene with confirmed germline LoF mechanism qualifies for PVS1 at full strength.
Frameshift variant creating PTC at codon 184 (NMD expected)BAP1 loss-of-function is established germline disease mechanism per literature review (PMID:35051358PMID:35348477
PM2 supporting Pathogenic
This variant is absent from gnomAD v2.1 and v4.1 population databases, meeting the non-VCEP PM2 threshold of allele frequency below 0.1%.
Absent from gnomAD v2.1 (0 alleles)Absent from gnomAD v4.1 (0 alleles)Absent from gnomAD-Canada v1.0
Assessed · not applied
Pathogenic
PS2 No de novo data available for this variant.
PS3 No variant-specific functional studies identified.
PS4 Variant is absent from ClinVar and no case reports with this specific variant were identified in the literature reviewed.
PM1 This variant does not lie in a statistically significant mutational hotspot in BAP1.
PM6 No de novo observations reported for this variant.
PP1 No segregation data available for this variant.
PP3 Per PMC6185798, splice prediction scores are not stacked with PVS1 for the same variant.
PP4 No patient phenotype data provided for this specific variant assessment.
PP5 Variant is absent from ClinVar; no expert panel classification available to support PP5.
Benign
BS2 No data on observation of this variant in healthy adults.
BS3 No variant-specific functional studies demonstrating a benign effect were identified.
BS4 No segregation data available for assessing lack of cosegregation with disease.
BP2 No data on observation of this variant in trans with a known pathogenic variant in BAP1.
BP4 No in silico evidence supporting a benign effect.
BP5 No data on an alternative molecular basis for disease in affected individuals carrying this variant.
BP6 No reputable source has classified this variant as benign.
N/A · 9 PS1 · PM4 · PM5 · PP2 · BA1 · BS1 · BP1 · BP3 · BP7
Research & evidence
Population frequency
gnomAD v4.1 screenshot
gnomAD v4.1
gnomAD v2.1 screenshot
gnomAD v2.1
v4.1
Absent from gnomAD v4.1.
v2.1
Absent from gnomAD v2.1.
🇨🇦 CA
Absent from gnomAD-Canada v1.0.
Allele frequency by ancestry
three datasets · side by side
gnomAD v4.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD v2.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD Canada 🇨🇦
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar screenshot
ClinVar
This variant is absent from ClinVar.
SpliceAI screenshot
In silico
SpliceAI predicts possible splice impact for this variant (max delta score = 1.00).
Functional / OncoKB screenshot
Functional Likely Oncogenic
OncoKB identified variant-specific curated literature and context relevant to functional review; biological-effect context: Likely Loss-of-function; curated oncogenicity label: Likely Oncogenic.
OncoKB ↗
COSMIC screenshot
COSMIC
Cancer hotspots screenshot
Cancer hotspots
Somatic evidence Not in COSMIC / hotspots
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
Hotspots
This variant does not lie in a statistically significant hotspot.
Sources & reference links
8Sources
ClinVar
gnomAD v2.1
gnomAD v4.1
gnomAD-Canada
SpliceAI
OncoKB
COSMIC
Cancer hotspots
Triaged references · 2 PMIDs not cited in assessment
18757409 ↗ BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. ONCOKB
21874000 ↗ Germline BAP1 mutations predispose to malignant mesothelioma. ONCOKB